ISPE, a global not-for-profit association of 24,000 pharmaceutical science and manufacturing professionals, announces the release of the Baseline Guide Risk-based Manufacture of Pharmaceutical Products (Risk-MaPP) to be available third quarter 2010.
 
Risk-MaPP provides a scientific risk-based approach, based on ICH Q9, to manage the risk of cross contamination in order to achieve and maintain an appropriate balance between product quality and operator safety.
 
A Live Webinar entitled "Risk-MaPP: What Is It and Why You Need It" will be held on Sept. 14 as an introduction for professionals not yet familiar with, or who seek a better understanding of, the importance of Risk-MaPP. The webinar is a prerequisite to upcoming conference sessions, and should be attended by conference delegates for maximum understanding. A recorded version of the webinar will also be available in late September.
 
Upcoming conference events featuring Risk-MaPP include:
• ISPE Brussels Conference: Sept. 20-23; Brussels, Belgium
• ISPE Risk-MaPP Conference: Oct. 4-5  Washington D.C.
•  Japan Conference: Oct. 21-22; Tokyo, Japan
• Singapore Conference, Oct. 25-26; Singapore
• ISPE 2010 Annual Meeting: Nov. 7-10, Orlando
 
For more information,  visit: http://www.ispe.org/Risk-MaPP.